Si-bone, Inc. key statistics and ratios
In fiscal 2025, Si-bone, Inc. had return on equity of -11.0%, an operating margin of -11.1%, debt equal to 20.3% of equity and a current ratio of 8.55. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 89.3% | 91.3% | 89.9% | 87.9% | 88.4% | 85.2% | 78.8% | 79.0% | 79.6% | 79.5% |
| Operating margin | −36.2% | −21.6% | −53.5% | −52.6% | −57.3% | −56.0% | −33.8% | −21.1% | −11.1% | −8.3% |
| Net margin | −48.0% | −31.5% | −57.1% | −59.5% | −62.8% | −57.6% | −31.2% | −18.5% | −9.4% | −6.9% |
| Free-cash-flow margin | −37.5% | −27.9% | −50.6% | −45.3% | −50.9% | −48.1% | −19.1% | −13.7% | −4.5% | −2.1% |
| Return on equity | — | — | −50.1% | −37.6% | −37.2% | −52.6% | −32.4% | −18.4% | −11.0% | −8.1% |
| Return on assets | −64.3% | −20.0% | −30.1% | −25.7% | −27.4% | −35.2% | −22.3% | −13.4% | −8.1% | −6.0% |
| Asset turnover | 1.34 | 0.64 | 0.53 | 0.43 | 0.44 | 0.61 | 0.72 | 0.73 | 0.86 | 0.88 |
| Current ratio | 4.46 | 15.11 | 5.94 | 16.20 | 10.41 | 6.50 | 9.01 | 7.66 | 8.55 | 9.15 |
| Debt to equity | — | 44.3% | 63.5% | 24.2% | 26.6% | 36.3% | 21.3% | 21.6% | 20.3% | 19.7% |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m | n/m |
| R&D as % of revenue | 11.5% | 9.7% | 10.8% | 12.9% | 13.8% | 12.8% | 10.8% | 9.9% | 8.7% | 8.4% |
| Capital spending as % of revenue | 1.0% | 1.7% | 3.6% | 3.5% | 7.1% | 8.9% | 5.6% | 6.3% | 4.2% | 3.2% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 79.1% | 79.1% | 79.7% | 79.8% | 79.8% | 79.0% | 79.8% | 79.5% |
| Operating margin | −18.9% | −11.2% | −15.8% | −14.4% | −11.1% | −4.4% | −9.7% | −8.6% |
| Net margin | −16.3% | −9.2% | −13.8% | −12.7% | −9.4% | −2.9% | −8.2% | −7.3% |
| Free-cash-flow margin | −6.8% | −2.2% | −14.8% | −4.0% | −1.3% | 0.8% | −6.5% | −1.4% |
| Current ratio | 8.25 | 7.66 | 8.53 | 8.38 | 7.97 | 8.55 | 9.99 | 9.15 |
| Debt to equity | 21.9% | 21.2% | 21.2% | 20.8% | 20.6% | 20.0% | 19.9% | 19.5% |
| R&D as % of revenue | 9.9% | 7.9% | 9.6% | 8.9% | 8.7% | 7.7% | 8.0% | 9.3% |
Financial health
- Short-term assets cover short-term liabilities $220m of assets due within a year against $24m of liabilities due within a year.
- Short-term assets cover long-term liabilities $220m short-term assets against $42m of longer-dated liabilities.
- More cash than debt $33m of cash against $36m of debt.
- Debt below 40% of shareholders' equity Debt is 20% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 26% to 20% over five years.
- A year's operating cash flow covers at least 20% of debt $2m of operating cash flow against $36m of debt.
- Operating profit covers interest at least five times over Operating income of −$18m against $2m of interest.
Moat
Weak moat
How hard Si-bone's competitive advantage looks for rivals to wear away, judged from 9 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 0 / 20
Cash operating profit has been a median -15.7% of total assets over 8 years.
- Pricing power 17 / 20
Gross margin has been a median 87.1%, moving by 4.9 percentage points (standard deviation) across 9 years.
- Durability 10 / 20
Operating margin has been a median -38.7%; its worst year was -64.8%.
- Cash conversion 0 / 20
Free cash flow was positive in 0 of 8 years, at a median -36.4% of revenue.
- Discipline 0 / 20
The diluted share count rose 38.8% over five years; stock-based pay has been a median 15.4% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Treace Medical Concepts, Inc. statistics
- Lakeland Industries Inc statistics
- Establishment Labs Holdings Inc. statistics
- Cerus Corp statistics
- Lemaitre Vascular Inc statistics
Head to head: SIBN vs TMCILAKE vs SIBNESTA vs SIBN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies